Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.
about
Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Additional induction chemother ...... ensity score matched analysis.
@en
Additional induction chemother ...... ensity score matched analysis.
@nl
type
label
Additional induction chemother ...... ensity score matched analysis.
@en
Additional induction chemother ...... ensity score matched analysis.
@nl
prefLabel
Additional induction chemother ...... ensity score matched analysis.
@en
Additional induction chemother ...... ensity score matched analysis.
@nl
P2093
P2860
P356
P1433
P1476
Additional induction chemother ...... ensity score matched analysis.
@en
P2093
Aizawa Rihito
Chuner Jiang
Fangzheng Wang
Quanquan Sun
Sakamoto Masoto
Tongxin Liu
Yuezhen Wang
P2860
P304
P356
10.7150/JCA.20461
P577
2018-01-01T00:00:00Z